Bogomolny Evgeny, Huleihel Mahmoud, Suproun Yelena, Sahu Ranjit K, Mordechai Shaul
Ben Gurion University, Department of Physics, Beer-Sheva 84105, Israel.
J Biomed Opt. 2007 Mar-Apr;12(2):024003. doi: 10.1117/1.2717186.
Fourier transform infrared microspectroscopy (FTIR-MSP) is potentially a powerful analytical method for identifying the spectral properties of biological activity in cells. The goal of the present research is the implementation of FTIR-MSP to study early spectral changes accompanying malignant transformation of cells. As a model system, cells in culture are infected by the murine sarcoma virus (MuSV), which induces malignant transformation. The spectral measurements are taken at various postinfection time intervals. To follow up systematically the progress of the spectral changes at early stages of cell transformation, it is essential first to determine and validate consistent and significant spectral parameters (biomarkers), which can evidently discriminate between normal and cancerous cells. Early stages of cell transformation are classified by an array of spectral biomarkers utilizing cluster analysis and discriminant classification function techniques. The classifications indicate that the first spectral changes are detectable much earlier than the first morphological signs of cell transformation. Our results point out that the first spectral signs of malignant transformation are observed on the first and third day of postinfection (PI) (for NIH/3T3 and MEF cell cultures, respectively), while the first visible morphological alterations are observed only on the third and seventh day, respectively. These results strongly support the potential of developing FTIR microspectroscopy as a simple, reagent-free method for early detection of malignancy.
傅里叶变换红外显微光谱法(FTIR-MSP)可能是一种用于识别细胞中生物活性光谱特性的强大分析方法。本研究的目的是应用FTIR-MSP来研究细胞恶性转化过程中伴随的早期光谱变化。作为一个模型系统,培养的细胞被鼠肉瘤病毒(MuSV)感染,该病毒可诱导恶性转化。在感染后的不同时间间隔进行光谱测量。为了系统地跟踪细胞转化早期光谱变化的进展,首先必须确定并验证一致且显著的光谱参数(生物标志物),这些参数能够明显区分正常细胞和癌细胞。利用聚类分析和判别分类函数技术,通过一系列光谱生物标志物对细胞转化的早期阶段进行分类。分类结果表明,最早的光谱变化比细胞转化的首个形态学迹象早得多就能被检测到。我们的结果指出,恶性转化的首个光谱迹象分别在感染后第一天和第三天观察到(分别针对NIH/3T3和MEF细胞培养物),而首个可见的形态学改变分别在第三天和第七天才观察到。这些结果有力地支持了将FTIR显微光谱法开发为一种用于早期检测恶性肿瘤的简单、无需试剂的方法的潜力。